Release Date:  September 4, 1998



National Institute of Allergy and Infectious Diseases

The Opportunistic Infections Research Branch, Therapeutics Research Program,
Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID),
NIH, has a requirement to develop therapies for the treatment of AIDS and
associated opportunistic infections.  The purpose of this RFP is to seek
responsible offers for establishment of drug screening capability.  This contract
is to support activities in the microbiological and animal model testing of new
candidate drugs.


This contract will involve the use of information on compounds, which may be
confidential and proprietary.  All offerors except those deemed by the Government
to have an actual or apparent conflict of interest are eligible to compete. 
Organizations that are, or subsidiaries to, pharmaceutical or chemical companies
(i.e., an organization which sells drugs and/or chemicals to the general public
for profit) are examples of organizations that are excluded from competition. 
Documentation of commercial interests, such as investors' prospectus or recent
audit, must be supplied in an offeror's business proposal.  The Government
reserves the right to exclude any offeror.  If there is ANY question about
potential conflicts or APPARENT conflicts, contact the Contracting Officer.

An Advance Understanding will be inserted in the resultant contract stating that
the NIAID shall be notified if the Contractor's conflict of interest status has
changed and that a determination shall be made regarding the continuation of the

It is anticipated that one cost reimbursement, completion type contract will be
awarded for a period of seven years, beginning approximately August 17, 1999. 
RFP NIH-NIAID-DAIDS-99-15 is now available electronically and may be accessed
through the NIAID Contract Management Branch (CMB) Home Page at the following
URL:  Once at the NIAID/CMB Home Page, click
on the "RFPs" link and then click on "RFP NIH-NIAID-DAIDS-99-15."

Note that the RFP for this acquisition has been revised to include only the Work
Statement, Deliverable and Reporting Requirements, Special Requirements and
Mandatory Qualification, if any, the Technical Evaluation Criteria, and the
Specific RFP Instructions and Provisions.  All information required for the
submission of an offer will be contained in the electronic RFP package. 
Following proposal submission and the initial review process, offerors comprising
the competitive range will be requested to provide additional documentation to
the Contracting Officer.

Responses to this RFP will be due on November 13, 1998.  Any  responsible offeror
may submit a proposal that will be considered by the Government.  This
advertisement does not commit the Government to award a contract.


Point of contact

Ross Kelley
National Institute of Allergy and Infectious Diseases
6003 Executive Boulevard, Room 3C07
Bethesda, MD  20892-7610
Telephone:  (301) 402-2234
FAX:  (301) 402-0972

No collect calls will be accepted.

Return to Volume Index

Return to NIH Guide Main Index

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER)
  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.